Yifeng Pharmary(SH:603939)2022-10-28 16:00Financial Performance - Total revenue for Q3 2022 reached CNY 4,597,604,480.14, representing a year-on-year increase of 28.01%[4] - Net profit attributable to shareholders was CNY 247,174,375.62, up 29.27% compared to the same period last year[4] - The net profit after deducting non-recurring gains and losses was CNY 235,293,329.02, reflecting a 25.31% increase year-on-year[4] - Basic earnings per share for the period was CNY 0.34, an increase of 25.93% compared to the previous year[5] - Net profit for the third quarter of 2022 was ¥916,526,052.63, compared to ¥768,717,317.68 in the same quarter of 2021, reflecting an increase of approximately 19.25%[23] - Earnings per share for the third quarter of 2022 were ¥1.15, up from ¥0.98 in the same quarter of 2021[26] - The total comprehensive income attributable to the parent company for the third quarter of 2022 was ¥781,085,241.22, compared to ¥695,956,485.57 in the same quarter of 2021[25] Assets and Liabilities - The total assets at the end of the reporting period amounted to CNY 19,053,207,470.48, a growth of 11.74% from the end of the previous year[5] - As of September 30, 2022, the company's total assets amounted to RMB 19,053,207,470.48, an increase from RMB 17,052,036,874.58 at the end of 2021[19] - Total liabilities as of the third quarter of 2022 amounted to ¥10,466,926,021.82, compared to ¥9,187,488,876.05 in the previous year, showing an increase of about 13.93%[20] - Total equity as of the third quarter of 2022 was ¥8,586,281,448.66, an increase from ¥7,864,547,998.53 in the same period of 2021, representing a growth of approximately 9.16%[20] Cash Flow - Cash flow from operating activities for the year-to-date increased by 38.51%, primarily due to the growth in sales revenue[8] - In the first three quarters of 2022, the cash inflow from operating activities was CNY 14,172,638,927.69, an increase from CNY 11,824,479,083.21 in the same period of 2021, representing a growth of approximately 19.0%[27] - The net cash flow from operating activities for the first three quarters of 2022 was CNY 2,308,090,112.73, compared to CNY 1,666,350,141.85 in 2021, indicating a year-over-year increase of about 38.5%[27] - The total cash outflow from operating activities was CNY 11,864,548,814.96, up from CNY 10,158,128,941.36 in the previous year, reflecting an increase of approximately 16.8%[27] - The cash and cash equivalents at the end of the period were CNY 2,453,607,708.15, compared to CNY 1,478,307,753.23 at the end of the same period last year, showing an increase of approximately 66.0%[28] Store Expansion and Acquisitions - In the first nine months of 2022, the company added 2,116 stores, including 817 new stores, 478 acquired stores, and 821 franchised stores, while closing 144 stores, bringing the total number of stores to 9,781[14] - The company completed two industry-related acquisitions in Q3 2022, acquiring 90% of a new company for RMB 25.2 million, involving 30 stores, and 70% of another new company for RMB 119 million, involving 85 stores[14] Expenses - Research and development expenses for the third quarter of 2022 were ¥13,769,981.10, compared to ¥8,973,621.99 in the same quarter of 2021, indicating an increase of about 53.5%[23] - The company paid CNY 633,020,131.41 in taxes, which is an increase from CNY 545,182,058.68 in the same period of 2021, reflecting a growth of about 16.1%[27] - The company’s cash outflow for employee compensation was CNY 2,379,214,152.42, compared to CNY 2,097,085,553.24 in the previous year, indicating an increase of approximately 13.4%[27]